A Peptide from the Beta‐strand Region of CD2 Protein that Inhibits Cell Adhesion and Suppresses Arthritis in a Mouse Model
Open Access
- 2 August 2010
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 76 (3) , 234-244
Abstract
Cell adhesion molecules play a central role at every step of the immune response. The function of leukocytes can be regulated by modulating adhesion interactions between cell adhesion molecules to develop therapeutic agents against autoimmune diseases. Among the different cell adhesion molecules that participate in the immunologic response, CD2 and its ligand CD58 (LFA‐3) are two of the best‐characterized adhesion molecules mediating the immune response. To modulate the cell adhesion interaction, peptides were designed from the discontinuous epitopes of the β‐strand region of CD2 protein. The two strands were linked by a peptide bond. β‐Strands in the peptides were nucleated by inserting a β‐sheet‐inducing Pro‐Gly sequence with key amino acid sequences from CD2 protein that binds to CD58. Using a fluorescence assay, peptides that exhibited potential inhibitory activity in cell adhesion were evaluated for their ability to bind to CD58 protein. A model for peptide binding to CD58 protein was proposed based on docking studies. Administration of one of the peptides, P3 in collagen‐induced arthritis in the mouse model, indicated that peptide P3 was able to suppress rheumatoid arthritis in mice.Keywords
This publication has 40 references indexed in Scilit:
- Design of β-Hairpin Peptides for Modulation of Cell Adhesion by β-Turn ConstraintJournal of Medicinal Chemistry, 2009
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Antigen-Specific Suppression of Experimental Autoimmune Encephalomyelitis by a Novel Bifunctional Peptide InhibitorThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Collagen-induced arthritisNature Protocols, 2007
- Suppression of immune responses in collagen‐induced arthritis by a rationally designed CD80‐binding peptide agentArthritis & Rheumatism, 2007
- Immune synapses in T-cell activationCurrent Opinion in Immunology, 2006
- Molecular Interactions Mediating T Cell Antigen RecognitionAnnual Review of Immunology, 2003
- Molecular dissection of the CD2-C58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional “hot spot”Journal of Molecular Biology, 2001
- NMR techniques for characterization of ligand binding: Utility for lead generation and optimization in drug discoveryBiopolymers, 1999
- Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patientsEuropean Journal of Immunology, 1992